Vinbiocare Biotechnology Joint Stock Company
Quick facts
Phase 2 pipeline
- Astra Zeneca COVID-19 vaccine · Immunology
This viral vector vaccine delivers genetic instructions for the SARS-CoV-2 spike protein to stimulate adaptive immune responses against COVID-19.
Competitive intelligence
For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors: